Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
In spite of significant progress in disease diagnosis and treatment, racial and ethnic minorities experience lower quality of care and poorer outcomes for certain conditions than non-minorit...
Cancer is a heterogeneous but related group of diseases wherein cells in certain tissues of the body proliferate uncontrollably and eventually invade adjacent and distant tissues. The oldest...
Each year, more monoclonal antibodies (mAbs) are approved by regulatory agencies to treat a wide range of diseases with an expected market value of over $200 billion by 2026. The advantage o...
Rapid genomic surveillance of pathogens can provide valuable insights, in order to guide public health interventions. Novel workflows using nanopore technology enables for real-time sequenci...
Date: November 08, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CET) Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational earl...
Date: November 8, 2022 Time: 1:00pm (SGT), 12:00pm (EST), 6:00am (CET) Antibodies are vital tools in many of the laboratory techniques that are used...
Date: November 3, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Aden...
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
Genome engineers can leverage an ever-expanding array of biological and computational tools to make targeted genetic changes. Maintaining and optimizing components ranging from reagent desig...
As we further understand the complexity and diversity of cellular states, it is becoming necessary for a cellular engineering toolbox, consisting of molecular tools that allow control over c...
Nucleic acid analysis is crucial for the diagnostics of infectious diseases such as COVID-19. CRISPR/Cas technology, beyond its broad application in gene editing, features, in this regard, a...
Clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 13 (Cas13) has been rapidly developed for nucleic-acid-based diagnostics by using its chara...
Date: November 2, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) As part of the immune response, inflammation plays a vital role in the host defense and is dictated by the balance bet...
My laboratory uses tools from pharmacology, genomics, and cell signaling to study two key aspects of cancer biology. First, we seek to understand how oncogenic signals, altered metabolic sta...
Traditional methods for pathogen detection are often expensive and time-consuming and requires a well-equipped laboratory. Here we present a low-cost, deployable paper-based biosensor device...
The Cas9 from Francisella novicida (FnCas9) has unique properties of target identification and engagement in terms of specificity, nature of double strand break as well as length of guide RN...
Simple and sensitive nucleic acid-based molecular detection plays a crucial role in the early diagnosis of infectious diseases and the rapid screening of cancers. CRISPR technology has recen...
The CRISPR revolution has begun and shows no signs of slowing down. CRISPR-Cas nuclease-based genome editing strategies hold great promise for the treatment of genetic disorders. However, a...
The COVID-19 pandemic highlights the need for diagnostics that can be rapidly adapted and deployed in a variety of settings. Several SARS-CoV-2 variants have shown worrisome effects on vacci...
Rapid, accurate and frequent detection of the RNA of SARS-CoV-2 and of serological host antibodies to the virus would facilitate the determination of the immune status of individuals who hav...
CRISPR/Cas gene editing technology has rapidly evolved over the last decade. Its versatility extends from creating targeted research-use disease models in cells and animals, to high-throughp...
Date: November 1, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 5:00pm (CET) Rapid and efficient organism identification and antimicrobial susceptibility reports are paramount for patient survival...
Date: November 01, 2022 Time: 7:00am (PDT), 10:00am (EDT), 3:00pm (CET) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data t...
Date: October 26, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) To control and monitor the epidemiology and diffusion of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Date: October 26, 2022 Time: 6:00am (PDT), 9:00pm (EDT), 3:00pm (CEST) In the global fight toward Hepatitis C elimination, hear insights into how to build a cost-effective screening program...
Date: October 20, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Bacterial and viral infections produce a wide range of similar signs and symptoms leading often to the inappropriate u...
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
